G0434 HCPCS Level II code: Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter
CMS terminated G0434: its last date of service was Dec 31, 2015. It stays here for looking up older claims; newer services need a current code.
Official description
G0434Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter
Short description: Drug screen multi drug class
HCPCS · United States
Medicare details
The indicators CMS publishes with G0434 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Clinical lab fee schedule – Price subject to national limitation amount
- Type of service
- Diagnostic laboratory
- BETOS category
- Lab tests - other (Non-Medicare fee schedule)
- Lab certification
- Toxicology
- Added
- Jan 1, 2011
- Terminated after
- Dec 31, 2015
Where G0434 sits
- 1G codesProcedures and professional services
- 2Terminated G0434Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code G0434 still valid?
No. CMS terminated G0434; its last date of service was Dec 31, 2015. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover G0434?
CMS lists G0434’s Medicare coverage as “Carrier judgment” and its pricing as “Clinical lab fee schedule – Price subject to national limitation amount”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G0434
All G codesG0427Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealthG0428Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)G0429Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)G0431Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounterG0432Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screeningG0433Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screeningG0435Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screeningG0436Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutesG0437Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutesG0438Annual wellness visit; includes a personalized prevention plan of service (pps), initial visitG0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visitG0442Annual alcohol misuse screening, 5 to 15 minutes